Intellia Therapeutics, Inc (NTLA) insider trading
Every open-market stock purchase and sale by Intellia Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- John M Leonard (CEO) and 1 other sold $310K in the last 90 days.
- Last insider buy: Fred E Cohen (Insider), $1.4M, 10 months ago.
Last 12 months: insiders bought $1.4M (1 buy) and sold $2.2M (15 sales). Last close $11.65 on Oct 21, 2026.
Recent NTLA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 2, 2026 | Michael P Dube (C-suite exec) | Sold | $23.2K |
| Aug 21, 2026 | John M Leonard (CEO) | Sold | $36.2K |
| Aug 20, 2026 | John M Leonard (CEO) | Sold | $251K |
| Jul 22, 2026 | Edward J Dulac III (CFO) | Sold | $91.2K |
| Jul 2, 2026 | Edward J Dulac III (CFO) | Sold | $84.2K |
| Jul 1, 2026 | Michael P Dube (C-suite exec) | Sold | $44.3K |
| Jun 9, 2026 | Muna Bhanji (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | William J Chase (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | William J Chase (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Fred E Cohen (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Fred E Cohen (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Brian Goff (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Georgia Keresty (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Georgia Keresty (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Brian Goff (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Jesse Goodman (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Jesse Goodman (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Frank Verwiel (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Frank Verwiel (Insider) | Bought (not open market) | — |
| Jun 9, 2026 | Muna Bhanji (Insider) | Bought (not open market) | — |
| Mar 2, 2026 | James Basta (VP) | Sold | $16.7K |
| Mar 2, 2026 | Eliana Clark (CTO) | Sold | $8.4K |
| Mar 1, 2026 | John M Leonard (CEO) | Bought (not open market) | — |
| Mar 1, 2026 | Edward J Dulac III (CFO) | Bought (not open market) | — |
| Mar 1, 2026 | David Lebwohl (C-suite exec) | Bought (not open market) | — |
Who's trading NTLA
- Michael P Dube, C-suite exec: sold $95K (3 sales), last Oct 2, 2026
- John M Leonard, CEO: sold $1.4M (6 sales), last Aug 21, 2026
- Edward J Dulac III, CFO: sold $234K (3 sales), last Jul 22, 2026
- Muna Bhanji, Insider: other filings, last Jun 9, 2026
- Fred E Cohen, Insider: bought $1.4M (1 buy), last Jun 9, 2026
- Georgia Keresty, Insider: other filings, last Jun 9, 2026
- Jesse Goodman, Insider: other filings, last Jun 9, 2026
- Frank Verwiel, Insider: other filings, last Jun 9, 2026
- William J Chase, Insider: other filings, last Jun 9, 2026
- Brian Goff, Insider: other filings, last Jun 9, 2026
- James Basta, VP: sold $112K (2 sales), last Mar 2, 2026
- Eliana Clark, CTO: sold $96K (2 sales), last Mar 2, 2026
- David Lebwohl, C-suite exec: sold $110K (1 sale), last Mar 1, 2026
- Birgit C Schultes, C-suite exec: sold $78.4K (1 sale), last Mar 1, 2026
Get free alerts when an insider at Intellia Therapeutics, Inc files a new trade →